OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The contribution of the gut-liver axis to the immune signaling pathway of NAFLD
Jiayi Liu, Anding Wu, Jingjing Cai, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26
Jiayi Liu, Anding Wu, Jingjing Cai, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26
Showing 1-25 of 26 citing articles:
NAFLD: An Emerging Causal Factor for Cardiovascular Disease
Mei Li, Horng‐Dar Wang, Xiao‐Jing Zhang, et al.
Physiology (2023) Vol. 38, Iss. 6, pp. 255-265
Closed Access | Times Cited: 23
Mei Li, Horng‐Dar Wang, Xiao‐Jing Zhang, et al.
Physiology (2023) Vol. 38, Iss. 6, pp. 255-265
Closed Access | Times Cited: 23
The role of microbiomes in gastrointestinal cancers: new insights
Aref Yarahmadi, Hamed Afkhami
Frontiers in Oncology (2024) Vol. 13
Open Access | Times Cited: 8
Aref Yarahmadi, Hamed Afkhami
Frontiers in Oncology (2024) Vol. 13
Open Access | Times Cited: 8
Maternal PFOS exposure in mice induces hepatic lipid accumulation and inflammation in adult female offspring: Involvement of microbiome-gut-liver axis and autophagy
Wenjie Yi, Jun-Wen Shi, Liying Wang, et al.
Journal of Hazardous Materials (2024) Vol. 470, pp. 134177-134177
Closed Access | Times Cited: 8
Wenjie Yi, Jun-Wen Shi, Liying Wang, et al.
Journal of Hazardous Materials (2024) Vol. 470, pp. 134177-134177
Closed Access | Times Cited: 8
Immunology of gut microbiome and liver in non-alcoholic fatty liver disease (NAFLD): mechanisms, bacteria, and novel therapeutic targets
С. К. Груздев, I. V. Podoprigora, О. А. Гизингер
Archives of Microbiology (2024) Vol. 206, Iss. 2
Open Access | Times Cited: 5
С. К. Груздев, I. V. Podoprigora, О. А. Гизингер
Archives of Microbiology (2024) Vol. 206, Iss. 2
Open Access | Times Cited: 5
Ginsenoside Rg5 Activates the LKB1/AMPK/mTOR Signaling Pathway and Modifies the Gut Microbiota to Alleviate Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet
Yingying Shi, Jianbo Chen, Di Qu, et al.
Nutrients (2024) Vol. 16, Iss. 6, pp. 842-842
Open Access | Times Cited: 5
Yingying Shi, Jianbo Chen, Di Qu, et al.
Nutrients (2024) Vol. 16, Iss. 6, pp. 842-842
Open Access | Times Cited: 5
Lupeol improves bile acid metabolism and metabolic dysfunction-associated steatotic liver disease in mice via FXR signaling pathway and gut-liver axis
Dongmei Qin, P Pan, Bo Lyu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116942-116942
Open Access | Times Cited: 5
Dongmei Qin, P Pan, Bo Lyu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116942-116942
Open Access | Times Cited: 5
The synergistic role of gut microbiota and RNA in metabolic diseases: mechanisms and therapeutic insights
Zhuo Huang, Qinyan Yao, Shuang Ma, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access
Zhuo Huang, Qinyan Yao, Shuang Ma, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access
Preparation, identification and in vivo study of antioxidant peptides from Haematococcus pluvialis residue
Yuling Zhang, Mengjia Zhu, Qingxin Zhou, et al.
Food Bioscience (2025), pp. 106140-106140
Closed Access
Yuling Zhang, Mengjia Zhu, Qingxin Zhou, et al.
Food Bioscience (2025), pp. 106140-106140
Closed Access
Advances in the pharmacological effects and molecular mechanisms of emodin in the treatment of metabolic diseases
Linyuan Yu, Yongliang Zhao, Yongli Zhao
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10
Linyuan Yu, Yongliang Zhao, Yongli Zhao
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10
A bibliometric analysis of macrophages associated with non-alcoholic fatty liver disease research from 2005 to 2023
Zhen Yang, Zhiwei Xiong, Qiuguo Wang, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24187-e24187
Open Access | Times Cited: 3
Zhen Yang, Zhiwei Xiong, Qiuguo Wang, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24187-e24187
Open Access | Times Cited: 3
The Role of Microbiota-Related Co-Metabolites in MASLD Progression: A Narrative Review
María Martín-Grau, Daniel Monleón
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 7, pp. 6377-6389
Open Access | Times Cited: 3
María Martín-Grau, Daniel Monleón
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 7, pp. 6377-6389
Open Access | Times Cited: 3
Oral Administration of Alcohol-Tolerant Lactic Acid Bacteria Alleviates Blood Alcohol Concentration and Ethanol-Induced Liver Damage in Rodents
Mi Sun Yun, Hee Eun Jo, Young‐Do Nam, et al.
Journal of Microbiology and Biotechnology (2024) Vol. 34, Iss. 4, pp. 838-845
Open Access | Times Cited: 2
Mi Sun Yun, Hee Eun Jo, Young‐Do Nam, et al.
Journal of Microbiology and Biotechnology (2024) Vol. 34, Iss. 4, pp. 838-845
Open Access | Times Cited: 2
Exploring the Regulatory Effect of Tegillarca granosa Polysaccharide on High‐Fat Diet‐Induced Non‐Alcoholic Fatty Liver Disease in Mice Based on Intestinal Flora
Xingwen Yang, Shiwei Yao, Qihong Jiang, et al.
Molecular Nutrition & Food Research (2024) Vol. 68, Iss. 14
Closed Access | Times Cited: 2
Xingwen Yang, Shiwei Yao, Qihong Jiang, et al.
Molecular Nutrition & Food Research (2024) Vol. 68, Iss. 14
Closed Access | Times Cited: 2
The role of small intestinal bacterial overgrowth in obesity and its related diseases
Qinyan Yao, Zihan Yu, Qingguo Meng, et al.
Biochemical Pharmacology (2023) Vol. 212, pp. 115546-115546
Closed Access | Times Cited: 7
Qinyan Yao, Zihan Yu, Qingguo Meng, et al.
Biochemical Pharmacology (2023) Vol. 212, pp. 115546-115546
Closed Access | Times Cited: 7
Prediction and verification of the active ingredients and potential targets of Erhuang Quzhi Granules on non-alcoholic fatty liver disease based on network pharmacology
Si Li, Xi Wu, Yue Ma, et al.
Journal of Ethnopharmacology (2023) Vol. 311, pp. 116435-116435
Closed Access | Times Cited: 6
Si Li, Xi Wu, Yue Ma, et al.
Journal of Ethnopharmacology (2023) Vol. 311, pp. 116435-116435
Closed Access | Times Cited: 6
Small intestinal bacterial overgrowth in obese patients with biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: a cross-sectional study
Nicolás Ortiz‐López, Ana María Madrid, Larissa Aleman, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 1
Nicolás Ortiz‐López, Ana María Madrid, Larissa Aleman, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 1
Prebiotics targeting gut-liver axis to treat non-alcoholic fatty liver disease
Gabriele Castelnuovo, Nuria Pérez-Díaz-del-Campo, Marta Guariglia, et al.
Minerva Gastroenterology (2023) Vol. 70, Iss. 4
Closed Access | Times Cited: 3
Gabriele Castelnuovo, Nuria Pérez-Díaz-del-Campo, Marta Guariglia, et al.
Minerva Gastroenterology (2023) Vol. 70, Iss. 4
Closed Access | Times Cited: 3
Utilization of Food-Derived β-Glucans to Prevent and Treat Non-Alcoholic Fatty Liver Disease (NAFLD)
Nelson Kei, Vincent Wai‐Sun Wong, Susana Lauw, et al.
Foods (2023) Vol. 12, Iss. 17, pp. 3279-3279
Open Access | Times Cited: 3
Nelson Kei, Vincent Wai‐Sun Wong, Susana Lauw, et al.
Foods (2023) Vol. 12, Iss. 17, pp. 3279-3279
Open Access | Times Cited: 3
The role of the gut-liver axis in modulating non-alcoholic fatty liver disease through dietary patterns and microecological agents
Yucheng Fang, Ziyang Fang, Ziwei Li, et al.
Food Bioscience (2023) Vol. 56, pp. 103335-103335
Closed Access | Times Cited: 3
Yucheng Fang, Ziyang Fang, Ziwei Li, et al.
Food Bioscience (2023) Vol. 56, pp. 103335-103335
Closed Access | Times Cited: 3
Gymnemic acid alleviates gut barrier disruption and lipid dysmetabolism via regulating gut microbiota in HFD hamsters
Yumeng Li, Mingzhe Sun, Xutong Tian, et al.
The Journal of Nutritional Biochemistry (2024) Vol. 133, pp. 109709-109709
Closed Access
Yumeng Li, Mingzhe Sun, Xutong Tian, et al.
The Journal of Nutritional Biochemistry (2024) Vol. 133, pp. 109709-109709
Closed Access
Deciphering the Gut–Liver Axis: A Comprehensive Scientific Review of Non-Alcoholic Fatty Liver Disease
Samradhi Singh, Mona Kriti, Roberto Catanzaro, et al.
Livers (2024) Vol. 4, Iss. 3, pp. 435-454
Open Access
Samradhi Singh, Mona Kriti, Roberto Catanzaro, et al.
Livers (2024) Vol. 4, Iss. 3, pp. 435-454
Open Access
A new perspective in intestinal microecology: lifting the veil of exercise regulation of cardiometabolic diseases
Can Gao, Jiaxiao Wei, Changxu Lu, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access
Can Gao, Jiaxiao Wei, Changxu Lu, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access
Gut Microbiota Dysbiosis: A Neglected Risk Factor for Male and Female Fertility
Faeze Ahmadi Beni, Hossein Saffarfar, Anis Elhami, et al.
Cellular Microbiology (2024) Vol. 2024, Iss. 1
Open Access
Faeze Ahmadi Beni, Hossein Saffarfar, Anis Elhami, et al.
Cellular Microbiology (2024) Vol. 2024, Iss. 1
Open Access
Fermented rhubarb alleviates metabolic dysfunction-associated steatotic liver disease symptoms by modulating gut microbiota and activating the hepatic insulin signaling pathway
Heng Yuan, Junyu Zhou, Ting Zhang, et al.
Food Bioscience (2024), pp. 105720-105720
Closed Access
Heng Yuan, Junyu Zhou, Ting Zhang, et al.
Food Bioscience (2024), pp. 105720-105720
Closed Access
Immunology of gut microbiome and liver in non-alcoholic fatty liver disease (NAFLD): mechanisms, bacteria, and novel therapeutic targets
С. К. Груздев, I. V. Podoprigora, О. А. Гизингер
Authorea (Authorea) (2023)
Open Access
С. К. Груздев, I. V. Podoprigora, О. А. Гизингер
Authorea (Authorea) (2023)
Open Access
